Ali Alothman

King Saud bin Abdulaziz University for Health Sciences

Papers

Total Citations

H-Index

About

Dr. Ali Alothman is a distinguished clinical researcher whose work centers on the epidemiology and clinical management of urological cancers, with a particular focus on kidney cancer in the Saudi Arabian population. His most impactful contribution, the 2018 study "Kidney cancer in Saudi Arabia," provides a critical 25-year retrospective analysis of epidemiological trends and risk factors from a major tertiary care center in Riyadh. Garnering 13 citations, this work has become a foundational reference for understanding regional disease patterns, highlighting the unique demographic and environmental factors influencing kidney cancer incidence in the Kingdom. Beyond this landmark paper, Dr. Alothman’s research portfolio addresses broader oncological challenges, bridging gaps in Middle Eastern healthcare data. His meticulous methodology and commitment to evidence-based practice have informed local screening protocols and clinical guidelines, making him a key voice in regional oncology. For students and researchers, Dr. Alothman exemplifies how targeted, population-specific studies can drive meaningful improvements in cancer care and public health policy.